Amgen may not have an approved GLP-1 treatment just yet, but that could change in the future.

By Harshita Mary Varghese and Patrick Wingrove Jan 28 (Reuters) - Novo Nordisk spent nearly $500 million on U.S. advertising ...

Semaglutide is not the only medication in this drug class. Eli Lilly has developed its own GLP-1 receptor agonist, Tirzepatide, which edged out semaglutide in terms of weight loss in the recent ...

Telehealth company Ro is witnessing high demand for its new weight loss pill, Wegovy, especially among men who preferred pills over injections. Ro's strategic Super Bowl advertising, featuring Serena ...

More than 4,400 lawsuits have been filed since millions of Americans embraced GLP-1 drugs like Ozempic, Wegovy and Mounjaro ...

A NEW jab set to rival the likes of Mounjaro and Wegovy helped people lose up to 22 per cent of their body weight in less ...

Novo Nordisk (NVO) may see a post-earnings dip as Q4 includes conservative 2026 guidance despite oral Wegovy momentum. Click ...

By Amina Niasse NEW YORK, Jan 28 (Reuters) - Telehealth company Ro has had an influx of new customers seeking the newly ...

AFTER slimming down dramatically on weight loss jabs, mum-of-two Nicki Hari, 58, was left with a shocking side effect. As more and more women report shedding hair due to skinny jabs, Nicki says a ...

Consumer advocacy organization Public Citizen has filed (PDF) a Freedom of Information Act (FOIA) lawsuit against the Department of Health and Human Services (HHS) and the Department of Commerce (DOC) ...

The drugmaker's full-year results didn't seem to move the needle for investors who are instead focused on future growth ...

U.S. retailer Walmart on Wednesday said it has ​elevated 3,000 pharmacy technician roles to operations team lead positions, ...